SCHEMBL6921299

SCHEMBL6921299

O=C1CCCc2c1c1cc(F)ccc1n2Cc1ccccc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.69
HDAC6 Q9UBN7 2/20 0.69
PTGS1 P23219 1/20 0.56
PTGS2 P35354 1/20 0.56
CSNK2A2 P19784 1/20 0.53
CSNK2B P67870 1/20 0.53
CSNK2A1 P68400 1/20 0.53
ABCG2 Q9UNQ0 1/20 0.53
CA1 P00915 3/20 0.49
CA2 P00918 3/20 0.49
BRD4 O60885 1/20 0.48
PTGDR2 Q9Y5Y4 2/20 0.46
FABP4 P15090 1/20 0.46
CD74 P04233 1/20 0.45
MIF P14174 1/20 0.45
BCHE P06276 1/20 0.45
MAPT P10636 1/20 0.45
HK1 P19367 1/20 0.45
HTT P42858 1/20 0.45
HKDC1 Q2TB90 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6923513 0.92 HDAC1 (0.76) HDAC1HDAC6PTGS1PTGS2CA1
SCHEMBL6925477 0.88 PTGS1 (0.65) HDAC1HDAC6PTGS1PTGS2CSNK2A2
SCHEMBL14894319 0.87 HDAC1 (0.79) HDAC1HDAC6PTGS1PTGS2FABP4
SCHEMBL6925062 0.86 PTGS1 (0.58) HDAC1HDAC6PTGS1PTGS2CSNK2A2
SCHEMBL30480036 0.85 HDAC1 (0.70) HDAC1HDAC6PTGS1PTGS2CSNK2A2
SCHEMBL6925178 0.85 HDAC1 (0.70) HDAC1HDAC6PTGS1PTGS2CSNK2A2
SCHEMBL7547764 0.84 HDAC1 (0.69) HDAC1HDAC6PTGS1PTGS2CSNK2A2
SCHEMBL6926059 0.84 PTGS1 (0.67) HDAC1HDAC6PTGS1PTGS2CA1
SCHEMBL10155031 0.83 BCHE (0.66) HDAC1HDAC6BCHE
SCHEMBL6919959 0.83 HTR6 (0.59) HDAC1HDAC6PTGS1PTGS2CSNK2A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6514968-B1 Treating a disease or condition in a mammal wherein the 5-HT receptor is implicated and modulation of 5-HT function is desired comprising PHARMACIA & UPJOHN COMPANY 2003-02-04 US disclosed
EP-1210329-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2002-06-05 EP disclosed
WO-2001017963-A2 AMINOALKOXY CARBAZOLES AND THEIR USE AS 5-HT LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2001-03-15 WO disclosed